- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -   

 

► About Danesh-Pajoohesh Fajr Company:

With over three decades of specialized experience in designing, manufacturing, and implementing advanced cryogenic equipment and biological product storage solutions, we are a pioneering and innovative force in the global health sector.
Our solutions are applied in the following areas:

*-National and regional biobanks

*-Blood banks and hospital blood transfusion centers

*-Biotechnology research centers

*-Source plasma collection centers (fixed and mobile)

*-Stem cell storage facilities

*-Pharmaceutical and life sciences R&D laboratories

We are also a trusted partner in project management, investment facilitation, and commercialization of biopharmaceutical products, particularly in the plasma industry, at both national and international levels.

*-Main Areas of Activity

1- Production of Biological Product Storage Equipment – Designing and manufacturing advanced cryogenic and ultra-low temperature systems for the preservation of plasma, vaccines, cell lines, and other sensitive biological products, in full compliance with international standards.

2- Project Management and Commercialization of Biopharmaceutical Products – Managing and fully implementing projects in the field of plasma-derived medicinal products, including:

*-Production of Plasma-Derived Medicinal Products

*-Establishment of Plasma Therapy and Cell Therapy Centers

*-Construction of Fixed and Mobile Source Plasma Collection Centers

*-Commissioning of Plasma Fractionation Plants

*-Establishment of Specialized Plasma Research Centers

Our focus is on commercialization, branding, and technology transfer to high-growth international markets, particularly member countries of the Islamic Development Bank such as Iraq, Indonesia, Saudi Arabia, the United Arab Emirates (Dubai), Oman, and Qatar.

Strategic Programs and Initiatives

*-Expanding international cooperation with leading companies from Europe, China, Australia, and other Muslim countries

*-Collaborating with startups, knowledge-based companies, accelerators, and science and technology parks in the field of research and commercialization of biopharmaceuticals

*-Acting as an intermediary for innovative companies engaged in biopharmaceutical production to facilitate rebranding and entry into global markets

*-Conducting feasibility studies and investment planning in plasma-related industries, in cooperation with government organizations, private investors, and international institutions

Global Market Status

*-The global cryogenic equipment market in 2024 exceeded USD 20 billion and is projected to grow at an annual rate of over 6% through 2030.

*-The global plasma-derived medicinal products market reached over USD 35 billion in 2024 and is expected to surpass USD 50 billion by 2030.

*-The strategic importance of plasma collection centers is increasing worldwide, as these centers are recognized as a vital part of the pharmaceutical *industry’s drug supply chain.

*-Vision:

An effective and innovative presence in the cryogenic and biopharmaceutical industries, holding a prominent position in both national and international markets.

*-Mission:

Combining advanced technology, scientific expertise, and strategic collaborations to deliver sustainable and scalable solutions in the biological and plasma industries, serving both domestic and global markets.

*-Conclusion & Future Outlook:

Leveraging strong expertise in cryogenic engineering and project management within the plasma pharmaceutical industry, Danesh-Pazhoohesh Fajr possesses the capability to execute large-scale industrial, research, and therapeutic projects in both domestic and international markets. Our strategic focus on member countries of the Islamic Development Bank ensures access to growing healthcare economies and cross-border investment opportunities.